US BANCORP \DE\ - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 171 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$662
-41.8%
740.0%0.00%
Q2 2023$1,137
-86.3%
74
-79.9%
0.00%
Q1 2023$8,276
+431.9%
368
+397.3%
0.00%
Q4 2022$1,556
-48.1%
74
-30.8%
0.00%
Q3 2022$3,000
+50.0%
107
+5.9%
0.00%
Q2 2022$2,000
-94.7%
101
-93.2%
0.00%
Q1 2022$38,000
+1166.7%
1,487
+1372.3%
0.00%
Q4 2021$3,000
+50.0%
1010.0%0.00%
Q3 2021$2,0000.0%101
-20.5%
0.00%
Q2 2021$2,000
-33.3%
127
+25.7%
0.00%
Q1 2021$3,0000.0%1010.0%0.00%
Q4 2020$3,0001010.00%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MASSMUTUAL TRUST CO FSB/ADV 235$2,1130.00%
View complete list of TRAVERE THERAPEUTICS INC shareholders